Year |
Citation |
Score |
2009 |
Bier A, Oviedo-Landaverde I, Zhao J, Mamane Y, Kandouz M, Batist G. Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target. Molecular Cancer Therapeutics. 8: 786-93. PMID 19372551 DOI: 10.1158/1535-7163.Mct-08-0930 |
0.327 |
|
2007 |
Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK, Sonenberg N. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. Plos One. 2: e242. PMID 17311107 DOI: 10.1371/Journal.Pone.0000242 |
0.395 |
|
2006 |
Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N. mTOR, translation initiation and cancer. Oncogene. 25: 6416-22. PMID 17041626 DOI: 10.1038/Sj.Onc.1209888 |
0.386 |
|
2006 |
Le Bacquer O, Martineau Y, Mamane Y. [When translation arises from its TORpor]. MéDecine Sciences : M/S. 22: 514-8. PMID 16687120 DOI: 10.1051/Medsci/2006225514 |
0.34 |
|
2006 |
Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N. mTOR signaling: implications for cancer and anticancer therapy. British Journal of Cancer. 94: 195-9. PMID 16404421 DOI: 10.1038/Sj.Bjc.6602902 |
0.339 |
|
2005 |
Mamane Y, Loignon M, Palmer J, Hernandez E, Césaire R, Alaoui-Jamali M, Hiscott J. Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 25: 43-51. PMID 15684621 DOI: 10.1089/Jir.2005.25.43 |
0.605 |
|
2004 |
Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N. eIF4E--from translation to transformation. Oncogene. 23: 3172-9. PMID 15094766 DOI: 10.1038/Sj.Onc.1207549 |
0.373 |
|
2003 |
Arguello M, Sgarbanti M, Hernandez E, Mamane Y, Sharma S, Servant M, Lin R, Hiscott J. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene. 22: 964-73. PMID 12592383 DOI: 10.1038/Sj.Onc.1206270 |
0.602 |
|
2002 |
Mamane Y, Grandvaux N, Hernandez E, Sharma S, Innocente SA, Lee JM, Azimi N, Lin R, Hiscott J. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection. Oncogene. 21: 6751-65. PMID 12360402 DOI: 10.1038/Sj.Onc.1205843 |
0.656 |
|
2002 |
Sharma S, Grandvaux N, Mamane Y, Genin P, Azimi N, Waldmann T, Hiscott J. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 3120-30. PMID 12218129 DOI: 10.4049/Jimmunol.169.6.3120 |
0.669 |
|
2002 |
Mariner JM, Mamane Y, Hiscott J, Waldmann TA, Azimi N. IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor alpha promoter. Journal of Immunology (Baltimore, Md. : 1950). 168: 5667-74. PMID 12023365 DOI: 10.4049/Jimmunol.168.11.5667 |
0.577 |
|
2002 |
Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T cell leukemogenesis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 22: 135-43. PMID 11846984 DOI: 10.1089/107999002753452746 |
0.667 |
|
2001 |
Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ, Barber GN, Hiscott J. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 20: 800-11. PMID 11314014 DOI: 10.1038/Sj.Onc.1204163 |
0.658 |
|
2000 |
Sharma S, Mamane Y, Grandvaux N, Bartlett J, Petropoulos L, Lin R, Hiscott J. Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. Aids Research and Human Retroviruses. 16: 1613-22. PMID 11080800 DOI: 10.1089/08892220050193047 |
0.686 |
|
2000 |
Lin R, Génin P, Mamane Y, Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Molecular and Cellular Biology. 20: 6342-53. PMID 10938111 DOI: 10.1128/Mcb.20.17.6342-6353.2000 |
0.593 |
|
2000 |
Lin R, Mamane Y, Hiscott J. Multiple regulatory domains control IRF-7 activity in response to virus infection. The Journal of Biological Chemistry. 275: 34320-7. PMID 10893229 DOI: 10.1074/Jbc.M002814200 |
0.639 |
|
2000 |
Mamane Y, Sharma S, Petropoulos L, Lin R, Hiscott J. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. Immunity. 12: 129-40. PMID 10714679 DOI: 10.1016/S1074-7613(00)80166-1 |
0.684 |
|
1999 |
Mamane Y, Heylbroeck C, Génin P, Algarté M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R, Hiscott J. Interferon regulatory factors: the next generation. Gene. 237: 1-14. PMID 10524230 DOI: 10.1016/S0378-1119(99)00262-0 |
0.671 |
|
1999 |
Génin P, Mamane Y, Kwon H, LePage C, Wainberg MA, Hiscott J. Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. Virology. 261: 205-15. PMID 10497106 DOI: 10.1006/Viro.1999.9852 |
0.605 |
|
1999 |
Lin R, Mamane Y, Hiscott J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Molecular and Cellular Biology. 19: 2465-74. PMID 10082512 DOI: 10.1128/Mcb.19.4.2465 |
0.602 |
|
1999 |
Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin R. Triggering the interferon response: the role of IRF-3 transcription factor. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 19: 1-13. PMID 10048763 DOI: 10.1089/107999099314360 |
0.66 |
|
Show low-probability matches. |